Trial intelligence / Profile preview

Ketorolac and lidocaine paracervical block for surgical abortion pain

NCT00617097Phase 3Completed

Sponsor
Johns Hopkins University
Start
Jan 2008
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of ketorolac in pain, sponsored by Johns Hopkins University. Primary endpoint: Pain During Specific Time Intervals Throughout D&C Procedure. Started Jan 2008; status: completed.

02

Drugs

ketorolac
03

Conditions

pain

Beyond the preview

Go deeper on NCT00617097.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00617097.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call